Wedbush lowers Perspective Therapeutics stock price target to $7
AI Summary
Wedbush lowered its price target for Perspective Therapeutics stock to $7. The headline does not provide the previous target or the analyst's reasoning.
Related Articles
Nigeria secures $3m investment in climate-smart agriculture at COP31
Punch Nigeria —
Lagos targets $50bn investment in 300 climate projects
Punch Nigeria —
Maersk opens new logistics consolidation centre in Indonesia
Container News —
Complaint filed to IRS in relation to Fifa head Gianni Infantino’s housekeeper
The Guardian —
BrightView Holdings, Inc. (BV) Q4 2026 Earnings Call Transcript
Seeking Alpha —
EuroDry Ltd. (EDRY) Q3 2026 Earnings Call Transcript
Seeking Alpha —